Frontlight ResearchEarly access
Trial site
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
- 3closed trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer1 trial
- Melanoma1 trial
- Prostate cancer1 trial
- Phase
- Phase 32 trials
- Phase 11 trial
- Status
- Completed3 trials
- Lead sponsor
- ECOG-ACRIN Cancer Research Group2 trials
- Memorial Sloan Kettering Cancer Center1 trial
Closed trials
Completed
Completed
Completed
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Site data: ClinicalTrials.govUpdated 12 Nov 2026